C4 Therapeutics
Hope Flaxman is a Research Scientist II at C4 Therapeutics, Inc., specializing in Proteomics. Prior to joining C4 Therapeutics, Hope worked as a Research Scientist I at Harvard University where they conducted structural and mechanistic studies focusing on molecular glues and their targets. With a Ph.D. in Chemistry and Chemical Biology from Harvard University and a Bachelor's Degree in Chemistry and Biology from Massachusetts Institute of Technology, Hope has a strong background in research and experience in various internships in economics, applied mathematics, and computer vision. Hope has also contributed to the field of chemistry by mentoring students, assisting in teaching, and collaborating with experts in the industry.
C4 Therapeutics
6 followers
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.